Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
BEA-BEST
1 other identifier
observational
100
1 country
1
Brief Summary
This is an observational study that will be enrolling University of Louisville patients who present to the Emergency Department in Acute Respiratory Failure. This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2021
CompletedStudy Start
First participant enrolled
September 9, 2021
CompletedFirst Posted
Study publicly available on registry
December 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedJanuary 20, 2025
June 1, 2024
3.6 years
August 1, 2021
January 17, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Measure the accuracy of POCUS for the diagnosis of acute respiratory failure
POCUS consists of an ultrasound examination at bedside. We will perform lung ultrasound and the pattern of lung ultrasound will be used to diagnose the cause of acute respiratory failure. The reference standard will be the the final diagnosis by the clinician. The accuracy measures will include sensitivity, specificity, positive predictive value, and negative predictive value.
2 years
Measure the accuracy of POCUS plus Eko for the diagnosis of acute respiratory failure. AI-assisted lung auscultation for the diagnosis of the case of acute respiratory failure.
POCUS was described above. Ekos consists of a digital stethoscope. The lung auscultation pattern will be used to determine the cause of acute respiratory failure. POCUS and Eko will be integrated to establish the cause of acute respiratory failure. The reference standard will be the final diagnosis by the clinician.
2 years
Agreement between POCUS and Eko CORE
We will measure Kappa statistic.
2 years
Study Arms (1)
Acute Respiratory failure
Patients presenting to the Emergency Department in acute respiratory failure. These patients may or may not have a diagnosis of chronic lung disease.
Interventions
This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.
Eligibility Criteria
Patients 18years and older, presenting to the Emergency Department in acute respiratory failure. These patients may or may not have a diagnosis of chronic lung disease. It may be necessary to enroll more than 100 subjects in order to achieve 100 completed datasets.
You may qualify if:
- Adults aged 18 years or older presenting to the ED or admitted to the hospital within 12 hours of enrollment
- Acute respiratory failure defined as new onset shortness of breath initiated within the last 7 days, and new or increasing need for oxygen therapy
- The patient or patient's legal health care proxy consents to participation
You may not qualify if:
- Unwillingness to consent
- Patients with trauma as the cause of ARF
- Patients with pneumothorax as the cause of ARF
- Inability to perform pulmonary POCUS or lung auscultation (e.g. dressing on the chest)
- Unwilling or unable to complete the minimum of 12 lung sound stethoscope recordings.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Louisvillelead
- Eko Devices, Inc.collaborator
Study Sites (1)
University of Louisville
Louisville, Kentucky, 40202, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rodrigo Cavallazzi, MD
University of Louisville
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Associate Professor of Medicine
Study Record Dates
First Submitted
August 1, 2021
First Posted
December 3, 2021
Study Start
September 9, 2021
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
January 20, 2025
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share